Tag: Aravive

November 27, 2019

Aravive Announces Pricing of Public Offering of Common Stock

The company announced the pricing of its public offering of its common stock for gross proceeds totaling US$25 million at...
November 24, 2019

5 Top NASDAQ Biotech and Pharma Stocks: Fulcrum Climbs 73 Percent

Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
November 12, 2019

Aravive and AstreZeneca Begin Phase 1/2 Study of AVB-500

The Phase 1/2 clinical trial of AVB-500 is being done in combination with durvalumab in patients with ovarian cancer.
September 27, 2019

Aravive Presents Positive Phase 1b Portion of Phase 1b/2 Study

The company presented the data in an oral presentation at the European Society for Medical Oncology Congress in Barcelona.
September 22, 2019

5 Top Weekly NASDAQ Biotech and Pharma Stocks: Lexicon Soars

Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
August 4, 2019

5 Top Weekly NASDAQ Biotech and Pharma Stocks: Exicure Leads

Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...